[
  {
    "id": "SPARTANS",
    "title": "Finding better ways to measure movement in adults with Down syndrome",
    "description": "SPARTANS will collect physical activity measures to help find better ways to measure movement in adults with Down syndrome. Volunteers will attend a single study visit lasting about two hours",
    "image": "exercise.jpeg",
    "assessments": [
      "height-weight",
      "cosmed-resting-energy",
      "cosmed-activity-energy"
    ],
    "team": [
      "Brian Helsel",
      "Keri Cox",
      "Joseph Sherman",
      "Annie Rice",
      "Julianne Clina"
    ],
    "social-story": {
      "TitleSlide": {
        "title": "SPARTANS"
      },
      "PurposeSlide": {
        "title": "What is the purpose of this study?",
        "text": "This study aims to find better ways to measure movement in adults with Down syndrome using wearable devices."
      },
      "TeamSlide": {
        "title": "Meet our team",
        "text": "A physical activity measurement study led by Dr. Brian Helsel, PhD"
      },
      "InclusionCriteriaSlide": {
        "title": "Inclusion Criteria",
        "criteria": [
          "Diagnosis of Down syndrome",
          "Greater than 18 years of age",
          "Able to walk independently",
          "Medical clearance to participate in physical activity"
        ]
      },
      "StudyLocationSlide": {
        "title": "Where is the study located?",
        "location": "Clinical Research Center"
      }
    }
  },
  {
    "id": "BOLD",
    "title": "Brain Outcomes and Lifestyle in Down syndrome (BOLD)",
    "description": "Adults with Down syndrome will either follow a weight loss program or receive general health information. The 12-month study includes monthly virtual meetings and up to 5 visits to KU Medical Center, with no cost for participation and compensation provided.",
    "image": "healthy-eating.jpeg",
    "assessments": ["height-weight"],
    "team": [
      "Lauren Ptomey",
      "Keri Cox",
      "Joseph Sherman",
      "Brian Helsel",
      "Jessica Danon"
    ],
    "social-story": {
      "Panopto": {
        "videoId": "0583cb9c-2609-4eb5-9ba3-b2440150255e"
      },
      "TitleSlide": {
        "title": "BOLD",
        "text": "Social Story Part 1"
      },
      "AboutSlide": {
        "title": "BOLD",
        "text": "Social Story Part 2"
      }
    }
  },
  {
    "id": "ABC-DS",
    "title": "Alzheimer's Biomarkers Consortium - Down Syndrome",
    "description": "Active involvement in this observational study empowers individuals with Down syndrome to play a pivotal role in uncovering who is more likely to develop Alzheimer’s disease. Findings from this study aim to drive progress in developing treatments and potentially slowing the progression of Alzheimer’s disease.",
    "image": "brain.jpeg",
    "assessments": [
      "medical-history-exam",
      "cognitive-movement",
      "study-partner-questionnaires",
      "blood-draw",
      "mri-scan",
      "pet-scan"
    ],
    "team": [
      "Lauren Ptomey",
      "Keri Cox",
      "Joseph Sherman",
      "Brian Helsel",
      "Jessica Danon"
    ],
    "social-story": {
      "TitleSlide": {
        "title": "Alzheimer's Biomarkers Consortium - Down Syndrome"
      },
      "AboutSlide": {
        "title": "ABC-DS",
        "text": "Social Story Part 2"
      },
      "TeamSlide": {
        "title": "Meet our team",
        "text": "A longitudinal study of Alzheimer's biomarkers led by Dr. Lauren Ptomey, PhD"
      }
    }
  }
]
